THE APEX TIMES
Former RFK Jr. adviser Calley Means says senior Trump administration officials sidelined the “Make America Healthy Again” agenda ahead of the midterms, prioritizing fundraising and industry-linked interests.
Calley Means, a former adviser to Robert F. Kennedy Jr., accused senior Trump administration officials on Monday of abandoning the White House’s “Make America Healthy Again” agenda, saying the effort was slowed by fundraising priorities and by outreach to major sugar-industry interests. Means’ allegations were reported by multiple outlets as the administration began reshuffling top staff after President Donald Trump removed Susie Wiles as White House chief of staff last week.
Means’ central claim is that officials deprioritized the so-called Maha agenda as the midterm elections approached, instead focusing on special interest groups and campaign-linked fundraising activities. Means also claimed that links to the sugar industry grew during the period when, according to his account, the administration was expected to push health policy deliverables connected to the Maha effort.
The dispute surfaced as Trump administration personnel changes moved into public view. In a White House release announcing a leadership change, the White House said President Trump named Stephen Miller as the 33rd White House chief of staff, citing the appointment as a successor to Susie Wiles. The release characterized Wiles’ tenure as successful and described Miller as someone who has served alongside Trump since early in the administration.
Means’ accusations were reported alongside additional claims about internal dynamics. The Washington Times and The Hill both reported that Means alleged Trump had been “subverted” or “thrown under the bus” by advisers Means tied to outside interests, framing the argument around process and influence rather than a specific statute or court filing.
The Maha agenda itself, as characterized in the reporting, is described as an initiative aimed at improving public health, but the record presented in the reports centers on Means’ account of what was deprioritized and when. The outlets did not indicate that a court, inspector general, or administrative record has formally substantiated Means’ claims about fundraising, industry influence, or specific policy stoppages.
Beyond the disputed internal narrative, the practical stakes are tied to how health and regulatory priorities are set inside the White House, including how quickly initiatives move from concept to implementation. If the administration faces competing pressure from donors and regulated industries, the resulting delays can affect when agencies issue guidance, pursue enforcement, or develop regulations that can shape costs for consumers and compliance burdens for regulated sectors.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...